Antioxidant activity of naringenin on various oxidants induced damages in ARPE-19 cells and HUVEC

International Journal of Ophthalmology

Volumn 8, Issue 10, 2008, Pages 1963-1967

  Lin, Bao Qin ^a   Chiou, George C Y ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

AMD; ARPE 19 cells; HUVEC; Naringenin

Indexed keywords

HYDROGEN PEROXIDE; NARINGENIN; SODIUM AZIDE; SODIUM IODIDE; TERT BUTYL HYDROPEROXIDE; TETRAZOLIUM BLUE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; CELL GROWTH; CELL HYPOXIA; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; PIGMENT EPITHELIUM; UMBILICAL VEIN;

EID: 56249137915     PISSN: 16725123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Engelmann K, Valtink M. RPE cell cultivation. Graefe's Arch Clin Exp Ophthalmol 2004;242(1):65-67
2. Algvere PV, Seregard S. Age-related maculopathy: pathogenetic features and new treatment modalities. Acta Ophthalmol Scand 2002;80 (2):136-143
3. Joussen AM. Cell transplantation in age related macular degeneration: current concepts and future hopes. Graefe's Arch Clin Exp Ophthalmol 2004;242(1):1-2
4. Lutty G, Grunwald J, Majji AB, Uyama M, Yoneya S. Changes in choriocapillaris and reinal pigment epithelium (RPE) in age-related macular degeneration. Mol Vis 1999;5:35
5. Ohtaka K, Machida S, Ohzeki T, Tanaka M and Kurosaka D. Protective effect of Hepatocyte growth factor against degeneration of the retinal pigment epithelium and photoreceptor in sodium iodate-injeted rats. Curr Eye Res 2006;31(4):347-355
6. Tso MO. Pathogenetic factors of aging macular degeneration. Ophthalmology 1985;92(5):628-635
7. Yong RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol 1987;31(5):291-306
8. Lu L, Hackett SF, Mincey A, Lai H, Campochiaro PA. Effects of different types of oxidative stress in RPE cells. J Cell Physiol 2006;206 (1):119-125
9. Eichler W, Yafai Y, Wiedemann P, Fengler D. Antineovascular agents in the treatment of eye diseases. Curr Pharm Des 2006;12(21): 2645-2660
10. Jeon SM, Kim HK, Kim HJ, Do GM, Jeong TS, Park YB, Choi MS. Enhanced therapeutic potential of naringenin phospholipid complex in rats. Transl Res 2007;149(1):15-21
11. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Enhanced therapeutic potential of naringenin phospholipid complex in rats. J Pharm Pharmacol 2006;58(9):1227-1233
12. Lien TF, Yeh HS, Su WT. Effect of adding extracted hesperetin, naringenin and pectin on egg cholesterol, serum traits and antioxidant activity in laying hens. Arch Anim Nutr 2008;62(1):33-43
13. Yu J, Wang L, Walzem RL, Miller EG, Pike LM, Patil BS. Antioxidant Activity of Citrus Limonoids, Flavonoids, and Coumarins.J Agric Food Chem 2005;53(6):2009-2014
14. Kent D, Sheridan C. Choroidal neovascularization: a wound healing perspective.Mol Vis 2003;9:747-755
15. Choi YJ, Lee MK, Lee YJ, Jeong YJ, Yoon Park JH, Sung Lim S, Kang YH. Inhibition of Hydrogen Peroxide-Induced Endothelial Apoptosis by 2′,4′,7-Trihydroxyflavanone, a Flavonoid Form.J Med Food 2004;7(4):408-416